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Abstract
The present study was conducted to document the association between plasma homocysteine levels and the presence of macrovascular angiopathy
with food and nutrient intake patterns among patients with Type II diabetes mellitus in Korea. Plasma total homocysteine concentration was analyzed
by HPLC-fluorescence detector method in 127 patients with non-insulin dependent diabetes mellitus. Logistic regression analyses were performed 
respectively to study the association of plasma homocysteine levels with clinical and dietary characteristics and macroangiopathy (MA). The average
plasma homocysteine level of patients with MA was 14.2 μmol/l, which was significantly higher than that of patients without MA (11.4 μmol/l). 
The proportions of patients with MA showed a significant difference, being 32.3% in hyperhomocysteinemic (>14.0 μmol/l) patients and 13.5% 
in others with homocysteine levels lower than 14.0 μmol/l. Odds ratios for macroangiopathy by tertile increase of plasma homocysteine concentration
were 1.633 (Q2) and 4.831 (Q3), when adjusted for age, sex, and cigarette smoking. Patients with MA consumed reduced amounts of vitamin B1,
B2, and folate. The results indicate that the plasma homocysteine levels are significantly increased in NIDDM patients who have macroangiopathy.
Dietary management such as increased fruits and vegetables and decreased potatoes and starches might be beneficial for the prevention of macroangiopathy
in diabetic patients.
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Introduction1)
Non-insulin dependent diabetes mellitus (NIDDM) and its 
vascular complications are markedly increasing in Korea (Park 
et al., 1997) due to rapid industrialization process and economic 
growth, which entail changes in lifestyle and food habits. The 
management of vascular complications associated with the 
NIDDM, therefore, is becoming one of the critical public health 
concerns and issues in Korea.
Hyperhomocysteinemia has been recently identified as an 
important risk factor for cardiovascular (Hoogeveen et al., 1998), 
cerebrovascular, and peripheral vascular diseases. Hyperhomo-
cysteinemia is found in up to 30-50% of patients with coronary 
artery disease and/or cerebrovascular disease (Robinson et al., 
1995). With regard to the attribution of plasma homocysteine 
levels to the coronary artery disease risk, it has been estimated 
that a 5 μmol/l increase in the plasma homocysteine level is 
equivalent to an approximately 0.52 nmol/l (20 mg/dl) increase 
in the total cholesterol level, and this will result in a 20% increase 
in the coronary artery disease risk (Rees & Rodgers, 1993). 
Controlling the plasma levels of homocysteine thus becomes a 
critical step in the management of patients with NIDDM.
Numerous investigators have reported on homocysteine con-
centrations among patients with atherosclerotic vascular diseases 
and diabetic patients. It has been reported that type II diabetic 
patients who had proteinuria and macrovascular disease (Araki 
& Sako., 1993; Hoffman et al., 1998; Hultberg et al., 1991; 
Munshi  et al., 1996; Vaccaro et al., 1997) had higher fasting 
homocysteine levels than nondiabetic control subjects. Most of 
the studies however, were conducted on western population and 
such studies on the Asians such as Koreans who show an 
increasing trend in the prevalence of NIDDM are limited. 
Fruits and vegetables contain various micronutrients such as 
folic acid and other anti-oxidant vitamins which are beneficial 
for the maintenance of plasma homocysteine levels within the 
optimum range. Several studies reported inverse relationships 
between plasma homocysteine with intakes of B vitamins such 
as folate (Hatzis et al., 2006) and of fruits and vegetables 
(Paterson  et al., 2006).
The purpose of this paper is to report the prevalence of 
hyperhomocysteinemia in NIDDM patients according to their 
respective vascular health status, and to document an association 
between food and nutrient intake and plasma homocysteine levels 
in these patients.
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Table 1. Clinical characteristics of diabetic patients
a
Diabetic patients
MA (n=24) nMA (n=103) All (n=127)
Age(y) 59.5 ± 7.6  55.7 ± 12.9  56.5 ± 12.2
Sex(male:female)  33.3：66.7  42.4：57.6 40.7：59.3
BMI 24.1 ± 5.3 24.1 ± 3.3 24.1 ± 3.7
Fasting blood glucose(mg/dl) 150.8 ± 53.2 152.5 ± 47.2 152.2 ± 48.2
Duration of NIDDM(y)  8.6 ± 7.6  6.8 ± 5.9  7.2 ± 6.3
Total cholesterol(mg/dl) 202.9 ± 43.1 193.8 ± 46.7 195.7 ± 45.9
Triglycerides(mg/dl) 180.6 ± 72.2  188.6 ± 191.4  187.0 ± 174.1
Systolic blood 
pressure(mmHg)* 138.9 ± 21.7 128.3 ± 22.1 130.5 ± 22.3
Diastolic blood 
pressure(mmHg)**  84.0 ± 11.2  78.3 ± 10.5  79.4 ± 10.9
Homocysteine(umol/I)* 14.2 ± 5.8 11.4 ± 3.1 11.9 ± 4.5
a  Values  are  the  mean ± SD
* Values with different alphabetical letters are significantly different from each other 
at  p＜0.05.
Methods
Subjects and dietary data collection
The study subjects were 127 NIDDM patients. We divided 
diabetic patients into two groups: (1) Those who have coronary 
artery disease, cerebrovascular disease, and peripheral vascular 
disease, were classified as patients with macroangiopathy(MA) 
complications, and (2) the rest, as patients with no macroan-
giopathy. The 24-hour recall dietary data were collected by a 
well-trained interviewer and analyzed using a Can-Pro (Korean 
Nutrition Society 2006) for nutrient and food group intake. This 
study was approved by the CHA University College of Medicine 
Human Investigation Review Committee. We included age, 
gender and BMI matched control subjects in the study. Any 
patient or control subjects who had known renal or other 
metabolic diseases or on any medications that might influence 
plasma homocysteine levels were excluded.
Analysis of plasma homocysteine and other biochemical 
measurements
Blood samples were drawn from subjects after an overnight 
fast and were immediately centrifuged at 2,800rpm for 15 
minutes at 4℃. The plasma was stored frozen at -70℃, and was 
analyzed for total homocysteine level. Plasma homocysteine was 
analyzed by the HPLC (Hitachi L-7100)-fluorescence detection 
method developed by Araki and Sako (1987). The plasma was 
thawed and treated with tri-n-butyl phosphine in dimethylfor-
mamide (DMFA) to release protein-bound homocysteine and to 
accomplish the reduction of mixed disulfides. Protein was 
precipitated with trichloroacetic acid and EDTA. After centri-
fugation at 3,000 × g for 5 minutes to remove protein, the 
supernatant was treated with ammonium 7-flurobenzo-2-oxa-1,3 
diazole-4-sulfonate (SBD-F, Sigma, USA) to derivatize homocy-
steine and plasma thiols. Derivatized thiols were separated on 
a Phenomenex Luna C18 column (250 × 4.6 mm I.D., 5 μm 
particle size) and measured using a Waters 474 scanning 
fluorescence detector. The mobile phase was 0.1 M sodium 
phosphate buffer, pH 6.0 containing 5% methanol v/v). The 
plasma glucose and cholesterol concentrations were analyzed by 
an Autoanalyzer at the clinical laboratory.
Statistical Analysis
All the results were statistically processed using a SAS 
program (SAS Institute, Inc., Cary, NC, USA). Patients were 
divided into (1) those having macrovascular disease and (2) those 
not, and were compared for their differences. One-way analysis 
of variance followed by Duncan's multiple range tests was 
performed and probability values less than 0.05 were considered 
statistically significant. Logistic regression analyses were per-
formed to study the association of hyperhomocysteinemia with 
the risk of macroangiopathy. We calculated odds ratios (ORs) 
and 95% confidence intervals (CIs) by tertiles of plasma 
homocysteine levels with the lowest tertile as a reference 
category. Age, sex and cigarette smoking were all considered 
as potential covariates. 
Results
Plasma homocysteine levels
Diabetes mellitus patients were divided into two groups: (1) 
those having macrovascular complications were designated MA 
group and (2) those not having macrovascular complications, 
nMA group.
In the diabetic patients without macroangiopathy, the plasma 
homocysteine level was 11.4 ± 3.1 μmol/l. In the diabetic patients 
with macroangiopathy, however, the plasma homocysteine level 
was 14.2 ± 5.8 μmol/l, which was significantly higher than the 
values of the patients with MA and the control by 23% and 25%, 
respectively (Table 1). Both systolic and diastolic blood pressures 
were increased in patients with MA compared to those without 
MA complications. There were no significant differences in the 
mean age, gender, BMI, fasting blood glucose, and the years 
of NIDDM between the two groups of diabetic patients.
The result of the logistic regression analysis on the association 
between plasma homocysteine levels with the risk of macroan-
giopathy is shown in Table 2. We calculated odds ratios by 
tertiles of plasma homocysteine with the lowest tertile as a 
reference. When adjusted for age, gender, and cigarette smoking, 
the odds ratios for MA were 1.633 (95% CIs = 0.606-4.398) and 
4.831 (95% CIs = 1.676-7.933) for Q2 and Q3, respectively.Namsoo Chang et al. 81
  
  
Fig. 1. Energy, protein, vitamins B1, B2 and folate intake of subjects
Table 2. Odds ratios for macroangiopathy by tertile increase of plasma 





Odds ratio 95% CI* Odds ratio 95% CI
Q1 (lowest) 1.0 1.0
Q2 2.211 0.879 -5.558 1.633 0.606-4.398
Q3 (highest) 2.763 1.130-6.760 4.831 1.676-7.922
P for trend 0.045 0.043
*  CI,  confidence  interval
†  Except  for  other  model  variable
‡ I n c l u d i n g  t e r m s  f o r  a g e ,  s e x  a n d  c i g a r e t t e  s m o k in g
$  Cutpoints  (tertiles):    9.76,  12.53mmol/L
Table 3. Odds ratios for hyperhomocysteinemia by tertile increase of vitamin
intake in diabetic patients*




Tertile 1 (lowest) 1.0
Tertile 2 1.438 0.284-7.284
Tertile 3 (highest) 0.637 0.097-4.192
Vitamin B1
b
Tertile 1 (lowest) 1.0
Tertile 2 0.590 0.121-2.877
Tertile 3 (highest) 0.055 0.012-0.735
Vitamin B2
c
Tertile 1 (lowest) 1.0
Tertile 2 0.831 0.144-4.790
Tertile 3 (highest) 0.747 0.142-3.928
Vitamin C
d
Tertile 1 (lowest) 1.0
Tertile 2 1.339 0.250-7.170
Tertile 3 (highest) 0.539 0.089-3.255
*  All  models  were  adjusted  for  age,  sex  and  smoking. 
OR=odds  ratio;  CI=confidence  interval
a  Cutpoints  (tertiles):  87.73,  121.84  μg/4.184  MJ/d
b  Cutpoints  (tertiles):  0.588,  0.706  mg/4.184  MJ/d
c  Cutpoints  (tertiles):  0.510,  0.658  mg/4.184  MJ/d
d  Cutpoints  (tertiles):  40.5,  57  mg/4.184  MJ/d
Table 4. Odds ratios for hyperhomocysteinemia of highest versus lowest tertile
of food group intake in diabetic patients
‡
Food groups Odds ratio 95% CI
Cereals and grain products 1.403 0.704-2.794
Potatoes and starches  2.804* 1.144-6.870
Sugars and sweets 1.934   0.795-4.704
Legumes and their products 1.596 0.734-3.467
Vegetables 0.646 0.295-1.417
Fruits  0.155* 0.057-0.422
Meats, poultry and their products 0.758 0.310-1.853
Eggs 0.428 0.157-1.170
Fish and shellfish 1.038 0.459-2.350
Milk and dairy products 0.632 0.232-1.718
‡  Including  terms  for  age,  gender,  energy  intake,  and  cigarette  smoking
Vitamin B intakes and macroangiopathy in diabetic patients
There was no difference in intakes of macronutrients such as 
energy and protein, but intakes of micronutrients such as 
thiamine, riboflavin, and folate were reduced in patients with 
macroangiopathy compared to those without MA. The difference 
in folate intake was still present when folate intake was adjusted 
for energy intake.
In order to investigate the association between vitamin B 
intakes and macroangiopathy in diabetic patients, a logistic 
regression analysis was conducted. After adjustment for energy 
intake, dietary folate and vitamin B1 intakes were inversely 
associated with the risk of hyperhomocysteinemia as shown in 
the Table 3. Compared with subjects in the lowest tertile of 
intake, those in the highest tertile had a calorie-adjusted OR of 
0.637 (95% CI = 0.097-4.192) and 0.055 (95% CI = 0.012- 
0.735), respectively. Also, dietary vitamin B2  and vitamin C 
intakes were inversely associated with the risk of hyperhomo-
cysteinemia. Compared with subjects in the lowest tertile of 
intake, those in the highest tertile had a calorie-adjusted OR of 
0.747 (95% CI = 0.142-3.928) and 0.539 (95% CI = 0.089- 
3.255), respectively. However, none of the logistic analysis data 
on the vitamin intake was statistically significant.82 Plasma homocysteine and food intake in diabetic patients
The result of the logistic analysis on the food group intake 
showed that the odds ratios for potatoes and starches and fruits 
were 2.804 (95% CI = 1.144-6.870) and 0.155 (95% CI = 0.057- 
0.422) when the data were adjusted for age, gender, energy 
intake, and cigarette smoking in patients with hyperhomo-
cysteinemia.
Discussion
We found that the plasma homocysteine levels in the diabetic 
patients with macroangiopathy were significantly higher com-
pared to those in the patients with no macrovascular 
complications or the non-diabetic normal control subjects. 
Diabetic patients with vascular complications consumed less 
amounts of B vitamins such as vitamin B1, B2, and folate. When 
vitamin intakes were adjusted for energy intake, the difference 
in folate intake was found to be still significant. After adjustment 
for energy intake, dietary intakes of folate, thiamin, riboflavin 
and vitamin C were inversely associated with the risk of 
hyperhomocysteinemia. 
In our study, the homocysteine level among the diabetic 
patients having the macrovascular disease was found notably 
high. In the study of 136 Japanese male and female non-insulin- 
dependent diabetes mellitus patients, Araki et al. (1993) reported 
that the concentration level of plasma homocysteine among the 
patients having macrovascular complications was higher than that 
among those having no macrovascular complications nor control. 
A study by Munshi et al. (1996) on the non-insulin dependent 
male patients under age 60, also, reported similar trends. 
We showed that the intakes of vitamin B1, B2 and folate were 
significantly low among the diabetic patients with macrovascular 
complications. Among several nutrients that are known to affect 
the plasma homocysteine level, the intakes of riboflavin and 
folate were investigated with particular attention. As was found 
out, the mean riboflavin intake in the MA group was lower than 
the recommended intake level for riboflavin. The metabolism of 
riboflavin is closely linked to the metabolism of other B vitamins 
such as folate, pyridoxine, and niacin. The deficiency of 
riboflavin, therefore, could cause a secondary deficiency in folate 
(Tan et al., 1984), leading to an increase of plasma homocysteine 
level (Selhub et al., 1993a).
Our results also showed that the folate intake in all three groups 
was far from the 400 μg, the recommended amount of folate 
intake for Koreans (Korean Nutrition Society, 2005), and was 
in fact the lowest in the MA group. Folate plays an important 
role in the process of transmethylation and transsulfuration, and 
is required in the metabolic pathway of removing homocysteine 
(Ubbink, 1994). It has been reported that the poor folate state 
can cause an increase in the total homocysteine concentration 
in the plasma, thereby increasing the danger of developing 
vascular complications (Berwanger et al., 1995; Masser et al., 
1994; Stampfer & Malinow, 1995). A sufficient supply of folate, 
on the other hand, can lower the homocysteine concentration, 
thereby decreasing the danger of developing vascular diseases 
(de Bree et al., 2001; Stampfer & Malinow, 1995). Insufficient 
intake of B vitamins like riboflavin, folate, vitamin B6, and 
vitamin B12 was shown to increase plasma homocysteine levels 
(Jacques et al., 2001; Selhub et al., 1993a; Selhub et al., 1993b).
The reasons for a higher mean homocysteine level observed 
in our diabetic subjects with MA might be attributed to their 
reduced intakes of riboflavin and folate, both of which can 
influence the plasma homocysteine levels. These findings 
strongly indicate that the intake of B vitamins that are known 
to influence homocysteine levels should be sufficiently increased 
for the diabetic patients to prevent vascular complications. From 
these results, we have come to a conclusion that a decreased 
level of folate intake causes an increase of homocysteine level 
in the blood, thereby leading to the complications of mac-
rovascular disease.
In our study, the odds ratios for the presence of hyper-
homocysteinemia was significantly decreased in patients whose 
consumption of fruits was in the highest quartile, confirming 
results of other investigators (Bogers et al., 2007; Hatzis et al., 
2006). Fruits and vegetables contain numerous micronutrients 
and functional ingredients with anti-oxidant properties which are 
helpful in keeping the homocysteine levels low thereby 
enhancing vascular health status. Increased fruits and vegetable 
intake has been effective in the improvement of plasma folate 
and homocysteine levels (Bermejo et al., 2007). In the other 
study, however, 4-week of increased fruits and vegetable 
consumption by 200 g/d (133 g/d for fruits and juice and 64 
g/d for vegetables) was not sufficient to change plasma folate 
and homocysteine concentrations (Bogers et al., 2007). 
Studies on the effect of folate and homocysteine on vascular 
health of the diabetic patients need to receive more attention to 
identify dietary factors that are associated with vascular 
complications in these patients. We are pursing our investigations 
further on these matters and more results will be discussed in 
future reports.
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